Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/phcogcommn/

The Janus Corner


Pharmacognosy Communications,2021,11,2,142.
Published:April 2021
Type:The Janus Corner

The Janus Corner

Mitchell Henry Wright

Leviathan Biosciences, Brisbane, Queensland, AUSTRALIA.


The genus Terminalia comprise over 250 species and are well-documented for their use in traditional (Ayurveda) medicines.1 Investigations into the medicinal potential of these plants has revealed that they not only contain numerous anti-inflammatory and antibacterial compounds2-7 but can prevent the development of cancers, as well as the induction of apoptosis of cancerous cells.8 Recently, an article that was written by Cock and Cheesman8 that summarises the available research on Terminalia spp. from a pharmacognostic standpoint. Focusing on the phytochemical profiles of these plants, as well as their therapeutic properties with respect to cancer proliferation, the review is a well-written paper and is a great resource for researchers and casual readers alike. The authors look at the applications to cancers and other conditions, the phytochemical profile (and antioxidant contents) of plants within the genus, including T. ferdinandiana, whose fruit are one of the richest natural sources of ascorbic acid. The chapter highlights the relationship between oxidative stress and cancer and explains the different biological compounds contained within Terminalia spp. that could contribute to preventing the formation of cancers. Finally, the review summarises the key points of the chapter, effectively collating the chapter through a series of dot points. Overall, this review is an informative read and offers a wonderful tool for both scientists and recreational plant enthusiasts. Read more...

Cite This Article

Vancouver Style :: Wright MHenry. The Janus Corner. Pharmacognosy Communications. 2021;11(2):142.  (324.83 KB)
MLA Style: Wright MHenry. The Janus Corner. Pharmacognosy Communications. 2021;11(2):142.  (324.83 KB)
CSE Style: Wright MHenry. The Janus Corner. Pharmacognosy Communications. 2021;11(2):142.  (324.83 KB)
APA Style: Wright MHenry. The Janus Corner. Pharmacognosy Communications. 2021;11(2):142.  (324.83 KB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.